hydroxyresveratrol est-il sûr pendant la grossesse ?
No regulatory prohibition or harmonised CLP CMR classification was found for hydroxyresveratrol/oxyresveratrol (CAS 29700-22-9), and no published reproductive/developmental toxicity or human teratogenicity data specific to oxyresveratrol were identified in searches of PubMed and regulatory sources. PubChem and supplier datasheets identify the substance (synonym oxyresveratrol) and physicochemical properties (logP ≈3.2) consistent with some potential for dermal absorption, so topical use could give low but measurable systemic exposure in adults. Sources: PubChem; supplier/product pages; PubMed searches for reproductive data (no oxyresveratrol-specific repro studies found).
Pregnancy-safe products containing hydroxyresveratrol










Related ingredients
Frequently asked questions
- hydroxyresveratrol est-il sûr pendant la grossesse ?
- No regulatory prohibition or harmonised CLP CMR classification was found for hydroxyresveratrol/oxyresveratrol (CAS 29700-22-9), and no published reproductive/developmental toxicity or human teratogenicity data specific to oxyresveratrol were identified in searches of PubMed and regulatory sources. PubChem and supplier datasheets identify the substance (synonym oxyresveratrol) and physicochemical properties (logP ≈3.2) consistent with some potential for dermal absorption, so topical use could give low but measurable systemic exposure in adults. Sources: PubChem; supplier/product pages; PubMed searches for reproductive data (no oxyresveratrol-specific repro studies found).
- hydroxyresveratrol est-il sûr pendant l'allaitement ?
- No evidence of harm to lactation or breastfeeding infants specific to oxyresveratrol was found. Because relevant human/animal lactation transfer data are lacking, and topical use can produce low systemic exposure, the conservative exposure score is low/measurable (e=1) but there is no mechanistic or reproductive evidence to raise hazard. Referenced supplier and chemical databases show identity and use in cosmetics; no CIR/SCCS/harmonised CLP classification was identified. (See sources.)
- hydroxyresveratrol est-il sûr pour la peau de bébé ?
- No infant-specific safety or developmental skin studies were identified. Oxyresveratrol (INCI: hydroxyresveratrol) is used as a topical cosmetic active (skin-lightening/antioxidant). Given measurable dermal absorption in adults is plausible (logP ≈3.2) and immature infant skin increases per‑kg exposure, exposure for 0–3‑year skin is increased by one category vs adults (adult e=1 → baby e=2). There is no infant-specific hazard or mechanism data to increase h or m. Sources: supplier/COSmetic ingredient listings and PubChem. (No EU Annex II/III/banned/restricted listings found.)
- Comment VeriMom évalue-t-il hydroxyresveratrol ?
- VeriMom évalue hydroxyresveratrol à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à hydroxyresveratrol pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à hydroxyresveratrol basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.